Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 4 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
jaideep mehta[Author]
(8 results)?
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.
Clin Cancer Res. 2023 Sep 15;29(18):3592-3602. doi: 10.1158/1078-0432.CCR-23-0092.
Clin Cancer Res. 2023.
PMID: 37491846
Clinical Trial.
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.
Haque T, Cadenas FL, Xicoy B, Alfonso-Pierola A, Platzbecker U, Avivi I, Brunner AM, Chromik J, Morillo D, Patel MR, Falantes J, Leitch HA, Germing U, Preis M, Lenox L, Lauring J, Brown RJ, Kalota A, Mehta J, Pastore F, Gu J, Mistry P, Valcárcel D.
Haque T, et al. Among authors: mehta j.
Leuk Res. 2023 Nov;134:107390. doi: 10.1016/j.leukres.2023.107390. Epub 2023 Sep 20.
Leuk Res. 2023.
PMID: 37776843
Clinical Trial.
Item in Clipboard
Effects of Acid-Reducing Agents on the Pharmacokinetics of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.
Kim B, Lee J, Jang H, Lee N, Mehta J, Jang SB.
Kim B, et al. Among authors: mehta j.
Adv Ther. 2022 Oct;39(10):4757-4771. doi: 10.1007/s12325-022-02286-z. Epub 2022 Aug 13.
Adv Ther. 2022.
PMID: 35962934
Free PMC article.
Item in Clipboard
Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies.
Jang SB, Kim KB, Sim S, Cho BC, Ahn MJ, Han JY, Kim SW, Lee KH, Cho EK, Haddish-Berhane N, Mehta J, Oh SW.
Jang SB, et al. Among authors: mehta j.
JTO Clin Res Rep. 2021 Sep 8;2(10):100224. doi: 10.1016/j.jtocrr.2021.100224. eCollection 2021 Oct.
JTO Clin Res Rep. 2021.
PMID: 34647107
Free PMC article.
Item in Clipboard
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer.
Huh KY, Lim Y, Yoon DY, Hwang JG, Sim S, Kang J, Wang J, Kim M, Jang SB, Shreeve SM, Mehta J, Haddish-Berhane N, Oh J, Lee S, Yu KS.
Huh KY, et al. Among authors: mehta j.
Lung Cancer. 2023 Jan;175:112-120. doi: 10.1016/j.lungcan.2022.11.021. Epub 2022 Dec 2.
Lung Cancer. 2023.
PMID: 36495784
Free article.
Clinical Trial.
Item in Clipboard
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.
Haddish-Berhane N, Su Y, Russu A, Thayu M, Knoblauch RE, Mehta J, Xie J, Gibbs E, Sun YN, Zhou H.
Haddish-Berhane N, et al. Among authors: mehta j.
Clin Pharmacol Ther. 2024 Mar;115(3):468-477. doi: 10.1002/cpt.3064. Epub 2023 Oct 12.
Clin Pharmacol Ther. 2024.
PMID: 37776107
Item in Clipboard
Cite
Cite